Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis.
Daviskas E, Anderson SD, Jaques A, Charlton B. Daviskas E, et al. Among authors: jaques a. Chest. 2010 Apr;137(4):861-8. doi: 10.1378/chest.09-2017. Epub 2009 Oct 31. Chest. 2010. PMID: 19880909 Clinical Trial.
Inhaled mannitol improves mucus clearance and, when administered over 2 weeks, it improves lung function in CF (Jaques et al. Chest. 2008;133(6):1388-1396). The changes in the physical properties of sputum after a 2-week treatment with mannitol were investigated in …
Inhaled mannitol improves mucus clearance and, when administered over 2 weeks, it improves lung function in CF (Jaques et al. Chest. …
Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
Bilton D, Robinson P, Cooper P, Gallagher CG, Kolbe J, Fox H, Jaques A, Charlton B; CF301 Study Investigators. Bilton D, et al. Among authors: jaques a. Eur Respir J. 2011 Nov;38(5):1071-80. doi: 10.1183/09031936.00187510. Epub 2011 Apr 8. Eur Respir J. 2011. PMID: 21478216 Clinical Trial.
Inhaled mannitol improves lung function in cystic fibrosis.
Jaques A, Daviskas E, Turton JA, McKay K, Cooper P, Stirling RG, Robertson CF, Bye PTP, LeSouëf PN, Shadbolt B, Anderson SD, Charlton B. Jaques A, et al. Chest. 2008 Jun;133(6):1388-1396. doi: 10.1378/chest.07-2294. Epub 2008 Mar 13. Chest. 2008. PMID: 18339790 Clinical Trial.
50 results